Tempus Ai Cl A (TEM)

$91.66 +2.36 (2.64%)
Market Cap 15.92B
Revenue (ttm) 693.40M
Net Income (ttm) -705.81M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -101.79%
Debt to Equity Ratio 1.85
Volume 9,313,400
Avg Vol 10,056,464
Day's Range N/A - N/A
Shares Out 173.73M
Stochastic %K 88%
Beta 4.87
Analysts Sell
Price Target $74.82

Company Profile

Tempus AI, Inc. operates as a healthcare technology company. It engages in providing next generation sequencing diagnostics, polymerase chain reaction profiling, molecular genotyping, and other anatomic and molecular pathology testing to healthcare providers, pharmaceutical companies, biotechnology companies, researchers, and other third parties. The company offers Insights, a license library of linked clinical, molecular, and imaging de-identified data, as well as a suite of analytical services...

Industry: Health Information Services
Sector: Healthcare
Phone: 800 976 5448
Fax: 800 893 0276
Address:
600 West Chicago Avenue, Suite 510, Chicago, United States
Alixc
Alixc Oct. 5 at 7:40 AM
$TEM https://finance.yahoo.com/news/tempus-ai-inc-tem-secures-064239061.html
0 · Reply
BasicTrader
BasicTrader Oct. 4 at 11:12 PM
$TEM dude I’m hoping for melt up. Let’s pump this shit #yolo
0 · Reply
trendtrader6
trendtrader6 Oct. 4 at 7:59 PM
$TEM daily and weekly. MACD's bullish. looks like a push to 110. if market melt up 120-130 possible medium term
0 · Reply
dukeofhb
dukeofhb Oct. 4 at 3:23 PM
$TEM first close above 90! Higher highs higher lows. Chart looks great for more upward momentum. Spiked up to 97 couple weeks ago but was there for a few seconds lol. Now we have some support with multiple retests and now closure. Expect the unexpected. But this will breakout to new all time highs 100+ soon imo. This has been volatile but a huge win if you were strong enough to hold through it all. In Nancy we trust. Good luck out there !!
0 · Reply
Srinivas111
Srinivas111 Oct. 4 at 2:56 PM
$TEM chart looking good
0 · Reply
LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 4 at 11:35 AM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $TEM Current Share Price: $91.66 Contracts: $TEM January 15, 2027 $95 Calls Scale in: $27.16- $33.19 Scale out: $42.24-$54.32 Can Easily Capture: 60% ROI Blended DTE: 469 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
TheStockTraderHub
TheStockTraderHub Oct. 4 at 2:51 AM
$TEM in a strong uptrend closed above it's resistance today, key level $93. A close above it can give it a move to $97 then clear skies to $100+ in coming days. Support: $88/$86
0 · Reply
QuantInsider
QuantInsider Oct. 4 at 2:48 AM
$TEM looking strong with that +16% breakout over five days Ambry upgrade lit the fire and now we’re seeing $1.83M in call sweeps pushing this momentum Buyers are hitting those Nov to Jan strikes, about 20% OTM Today’s big move was a $484.5k block in $90 calls, expiring mid-October Even with a +2.64% day, they’re still paying up If we stay above $90, we could see more follow-through Momentum is the name of the game right now
0 · Reply
tccudcs9966v
tccudcs9966v Oct. 3 at 10:37 PM
$TEM Why Tempus AI Stock Was Motoring Higher This Week A recent acquisition seems to be paying off already for the tech-forward healthcare data specialist. A subsidiary updated its cancer risk assessment platform to enhance breast cancer detection capabilities.
0 · Reply
muldoon92
muldoon92 Oct. 3 at 10:31 PM
$TEM ALL TIME closing high. Quite BOOLISH 😎 102 on deck for next week
0 · Reply
Latest News on TEM
Ambry Genetics Announces Improved EHR-Integrated Breast Cancer Risk Assessment Solution with Upgraded Tyrer-Cuzick Scoring Approach Incorporating Breast Density

Oct 1, 2025, 12:24 PM EDT - 3 days ago

Ambry Genetics Announces Improved EHR-Integrated Breast Cancer Risk Assessment Solution with Upgraded Tyrer-Cuzick Scoring Approach Incorporating Breast Density

Overlooked Stock: TEM Taps All-Time High on FDA Clearance

Sep 22, 2025, 4:30 PM EDT - 12 days ago

Overlooked Stock: TEM Taps All-Time High on FDA Clearance

Tempus Receives U.S. FDA 510(k) Clearance for Tempus xR IVD, its RNA NGS In Vitro Diagnostic Device

Sep 22, 2025, 8:30 AM EDT - 12 days ago

Tempus Receives U.S. FDA 510(k) Clearance for Tempus xR IVD, its RNA NGS In Vitro Diagnostic Device

Renalytix Announces Collaboration with Tempus to Advance Intelligent Risk Assessment in Diabetic Kidney Disease

Sep 15, 2025, 8:00 AM EDT - 19 days ago

Renalytix Announces Collaboration with Tempus to Advance Intelligent Risk Assessment in Diabetic Kidney Disease

Tempus AI stock is cheap as Murrey Math Lines points to more gains

Sep 12, 2025, 1:09 PM EDT - 22 days ago

Tempus AI stock is cheap as Murrey Math Lines points to more gains

Tempus AI: Is TEM Stock A 10x Growth Story?

Sep 12, 2025, 10:05 AM EDT - 22 days ago

Tempus AI: Is TEM Stock A 10x Growth Story?

Tempus AI Gains FDA Clearance For Updated Pixel To Boost Accuracy And Efficiency In Cardiac Imaging

Sep 11, 2025, 1:58 PM EDT - 23 days ago

Tempus AI Gains FDA Clearance For Updated Pixel To Boost Accuracy And Efficiency In Cardiac Imaging

Tempus Receives U.S. FDA Special 510(k) Clearance for Updated Tempus Pixel Device

Sep 11, 2025, 8:30 AM EDT - 23 days ago

Tempus Receives U.S. FDA Special 510(k) Clearance for Updated Tempus Pixel Device

Tempus Announces New Study in JCO Precision Oncology Validating PurIST® Algorithm for Enhanced Therapy Selection in Pancreatic Cancer

Sep 9, 2025, 8:30 AM EDT - 25 days ago

Tempus Announces New Study in JCO Precision Oncology Validating PurIST® Algorithm for Enhanced Therapy Selection in Pancreatic Cancer

Tempus AI, Inc. (TEM) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)

Sep 8, 2025, 4:25 PM EDT - 26 days ago

Tempus AI, Inc. (TEM) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)

After An Odd Start, Tempus AI Is Making A Beeline To The Good End Of The AI Rainbow

Sep 8, 2025, 10:58 AM EDT - 26 days ago

After An Odd Start, Tempus AI Is Making A Beeline To The Good End Of The AI Rainbow

Tempus AI: Evolving To Data Infrastructure And Monetization Options Platform

Sep 8, 2025, 4:43 AM EDT - 26 days ago

Tempus AI: Evolving To Data Infrastructure And Monetization Options Platform

Tempus AI: Strategic AI Advancements In Precision Oncology With Solid Stock Upside Potential

Sep 8, 2025, 2:35 AM EDT - 27 days ago

Tempus AI: Strategic AI Advancements In Precision Oncology With Solid Stock Upside Potential

Tempus AI: Expansive Opportunity As Healthcare Becomes More Heavily Scrutinized

Sep 4, 2025, 2:33 PM EDT - 4 weeks ago

Tempus AI: Expansive Opportunity As Healthcare Becomes More Heavily Scrutinized

Northwestern Medicine Becomes First Health System to Integrate Tempus' Generative AI Co-Pilot, David, Into Its EHR Platform

Sep 4, 2025, 8:30 AM EDT - 4 weeks ago

Northwestern Medicine Becomes First Health System to Integrate Tempus' Generative AI Co-Pilot, David, Into Its EHR Platform

Tempus to Participate in Morgan Stanley's 23rd Annual Global Healthcare Conference

Sep 3, 2025, 4:01 PM EDT - 4 weeks ago

Tempus to Participate in Morgan Stanley's 23rd Annual Global Healthcare Conference

Tempus Announces the Acquisition of Paige

Aug 22, 2025, 9:20 AM EDT - 6 weeks ago

Tempus Announces the Acquisition of Paige

Tempus AI: TEM Stock To $130?

Aug 18, 2025, 9:24 AM EDT - 6 weeks ago

Tempus AI: TEM Stock To $130?

Cathie Wood's Top 10 Stock Picks: Unpacking Ark Funds Innovation Picks For The Next Decade

Aug 14, 2025, 1:02 PM EDT - 7 weeks ago

Cathie Wood's Top 10 Stock Picks: Unpacking Ark Funds Innovation Picks For The Next Decade

AMD ARKF ARKG ARKK ARKQ ARKW ARKX

Tempus AI Stock: Is It A Buy Following Guidance Raise?

Aug 12, 2025, 7:45 AM EDT - 7 weeks ago

Tempus AI Stock: Is It A Buy Following Guidance Raise?

TEM Investors Have Opportunity to Join Tempus AI, Inc. Fraud Investigation with the Schall Law Firm

Aug 12, 2025, 4:42 AM EDT - 7 weeks ago

TEM Investors Have Opportunity to Join Tempus AI, Inc. Fraud Investigation with the Schall Law Firm

Tempus AI: Buy or Sell TEM Stock At $65?

Aug 11, 2025, 10:25 AM EDT - 7 weeks ago

Tempus AI: Buy or Sell TEM Stock At $65?

Tempus AI, Inc. (TEM) Q2 2025 Earnings Call Transcript

Aug 8, 2025, 11:18 AM EDT - 2 months ago

Tempus AI, Inc. (TEM) Q2 2025 Earnings Call Transcript

TEM Earnings Rally: A.I. Use in Health Care, Drug Discovery

Aug 8, 2025, 9:16 AM EDT - 2 months ago

TEM Earnings Rally: A.I. Use in Health Care, Drug Discovery

Tempus Reports Second Quarter 2025 Results

Aug 8, 2025, 6:00 AM EDT - 2 months ago

Tempus Reports Second Quarter 2025 Results

Tempus AI Gears Up For Q2 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

Aug 8, 2025, 2:34 AM EDT - 2 months ago

Tempus AI Gears Up For Q2 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

Tempus AI: Next Leg Up

Jul 31, 2025, 2:32 PM EDT - 2 months ago

Tempus AI: Next Leg Up

Tempus AI: Data‑Driven Margin Lift, But Cash Burn Extends My Hold Stance

Jul 30, 2025, 2:25 AM EDT - 2 months ago

Tempus AI: Data‑Driven Margin Lift, But Cash Burn Extends My Hold Stance

Tempus AI: Sustaining Growth Momentum With Acquisitions & Partnerships

Jul 29, 2025, 9:25 AM EDT - 2 months ago

Tempus AI: Sustaining Growth Momentum With Acquisitions & Partnerships

Tempus to Report Second Quarter 2025 Financial Results on August 8

Jul 22, 2025, 8:30 AM EDT - 2 months ago

Tempus to Report Second Quarter 2025 Financial Results on August 8

Tempus Receives U.S. FDA 510(k) Clearance for Tempus ECG-Low EF Software

Jul 16, 2025, 8:00 AM EDT - 2 months ago

Tempus Receives U.S. FDA 510(k) Clearance for Tempus ECG-Low EF Software

Apple Acquisition Buzz: Its $60 Billion War Chest Is Enough To Buy Datadog And Tempus

Jul 10, 2025, 12:15 PM EDT - 3 months ago

Apple Acquisition Buzz: Its $60 Billion War Chest Is Enough To Buy Datadog And Tempus

AAPL DDOG

Personalis Expands Tempus Strategic Collaboration to Bring Ultra-Sensitive Cancer Recurrence Testing to Colorectal Cancer Patients

Jul 9, 2025, 4:00 PM EDT - 3 months ago

Personalis Expands Tempus Strategic Collaboration to Bring Ultra-Sensitive Cancer Recurrence Testing to Colorectal Cancer Patients

PSNL

Tempus Expands AI-Enabled Care Pathway Intelligence Platform into Breast Cancer

Jul 8, 2025, 8:30 AM EDT - 3 months ago

Tempus Expands AI-Enabled Care Pathway Intelligence Platform into Breast Cancer

Tempus AI: High-Growth And High-Risk

Jul 1, 2025, 2:48 PM EDT - 3 months ago

Tempus AI: High-Growth And High-Risk

Tempus Announces Pricing of Upsized Offering of $650 Million of Convertible Senior Notes

Jun 30, 2025, 10:43 PM EDT - 3 months ago

Tempus Announces Pricing of Upsized Offering of $650 Million of Convertible Senior Notes

Tempus AI, Inc. Announces Proposed Convertible Senior Notes Offering to Optimize Capital Structure and Reduce Interest Expense

Jun 30, 2025, 7:00 AM EDT - 3 months ago

Tempus AI, Inc. Announces Proposed Convertible Senior Notes Offering to Optimize Capital Structure and Reduce Interest Expense

Ambry Genetics' CARE Program Validated for Accuracy in Identifying High-Risk Patients for Hereditary Cancer Testing

Jun 25, 2025, 5:00 PM EDT - 3 months ago

Ambry Genetics' CARE Program Validated for Accuracy in Identifying High-Risk Patients for Hereditary Cancer Testing

Tempus AI Is Well Worth Its Price Tag

Jun 25, 2025, 8:07 AM EDT - 3 months ago

Tempus AI Is Well Worth Its Price Tag

Tempus to Participate in TD Cowen's 4th Annual Tools/Dx Revolution Conference

Jun 17, 2025, 8:30 AM EDT - 3 months ago

Tempus to Participate in TD Cowen's 4th Annual Tools/Dx Revolution Conference

Shamis & Gentile, P.A. Notifies Investors It Has Filed a Complaint to Recover Losses Suffered by Purchasers of Tempus AI, Inc. and Sets a Lead Plaintiff Deadline of August 12, 2025

Jun 13, 2025, 3:00 PM EDT - 4 months ago

Shamis & Gentile, P.A. Notifies Investors It Has Filed a Complaint to Recover Losses Suffered by Purchasers of Tempus AI, Inc. and Sets a Lead Plaintiff Deadline of August 12, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Tempus AI, Inc. (TEM) and Encourages Shareholders to Learn More About the Investigation

Jun 12, 2025, 10:00 AM EDT - 4 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Tempus AI, Inc. (TEM) and Encourages Shareholders to Learn More About the Investigation

Tempus Announces Collaboration with Northwestern University's Abrams Research Center on Neurogenomics to Leverage AI for Alzheimer's Disease Research

Jun 12, 2025, 8:30 AM EDT - 4 months ago

Tempus Announces Collaboration with Northwestern University's Abrams Research Center on Neurogenomics to Leverage AI for Alzheimer's Disease Research

Tempus AI, Inc. (TEM) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

Jun 11, 2025, 10:00 AM EDT - 4 months ago

Tempus AI, Inc. (TEM) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

Alixc
Alixc Oct. 5 at 7:40 AM
$TEM https://finance.yahoo.com/news/tempus-ai-inc-tem-secures-064239061.html
0 · Reply
BasicTrader
BasicTrader Oct. 4 at 11:12 PM
$TEM dude I’m hoping for melt up. Let’s pump this shit #yolo
0 · Reply
trendtrader6
trendtrader6 Oct. 4 at 7:59 PM
$TEM daily and weekly. MACD's bullish. looks like a push to 110. if market melt up 120-130 possible medium term
0 · Reply
dukeofhb
dukeofhb Oct. 4 at 3:23 PM
$TEM first close above 90! Higher highs higher lows. Chart looks great for more upward momentum. Spiked up to 97 couple weeks ago but was there for a few seconds lol. Now we have some support with multiple retests and now closure. Expect the unexpected. But this will breakout to new all time highs 100+ soon imo. This has been volatile but a huge win if you were strong enough to hold through it all. In Nancy we trust. Good luck out there !!
0 · Reply
Srinivas111
Srinivas111 Oct. 4 at 2:56 PM
$TEM chart looking good
0 · Reply
LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 4 at 11:35 AM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $TEM Current Share Price: $91.66 Contracts: $TEM January 15, 2027 $95 Calls Scale in: $27.16- $33.19 Scale out: $42.24-$54.32 Can Easily Capture: 60% ROI Blended DTE: 469 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
TheStockTraderHub
TheStockTraderHub Oct. 4 at 2:51 AM
$TEM in a strong uptrend closed above it's resistance today, key level $93. A close above it can give it a move to $97 then clear skies to $100+ in coming days. Support: $88/$86
0 · Reply
QuantInsider
QuantInsider Oct. 4 at 2:48 AM
$TEM looking strong with that +16% breakout over five days Ambry upgrade lit the fire and now we’re seeing $1.83M in call sweeps pushing this momentum Buyers are hitting those Nov to Jan strikes, about 20% OTM Today’s big move was a $484.5k block in $90 calls, expiring mid-October Even with a +2.64% day, they’re still paying up If we stay above $90, we could see more follow-through Momentum is the name of the game right now
0 · Reply
tccudcs9966v
tccudcs9966v Oct. 3 at 10:37 PM
$TEM Why Tempus AI Stock Was Motoring Higher This Week A recent acquisition seems to be paying off already for the tech-forward healthcare data specialist. A subsidiary updated its cancer risk assessment platform to enhance breast cancer detection capabilities.
0 · Reply
muldoon92
muldoon92 Oct. 3 at 10:31 PM
$TEM ALL TIME closing high. Quite BOOLISH 😎 102 on deck for next week
0 · Reply
RisingLight919
RisingLight919 Oct. 3 at 9:37 PM
$TEM Why Tempus AI Stock Was Motoring Higher This Week A recent acquisition seems to be paying off already for the tech-forward healthcare data specialist. A subsidiary updated its cancer risk assessment platform, enhancing breast cancer detection capabilities.
0 · Reply
Alixc
Alixc Oct. 3 at 9:13 PM
$TEM bottom resistance 89.30 , from now just fllyyy baby
0 · Reply
Hognose
Hognose Oct. 3 at 8:06 PM
$TEM all time high close today.
0 · Reply
SakMG00d
SakMG00d Oct. 3 at 8:05 PM
$TEM Beautiful close. LFG
0 · Reply
Clemens300
Clemens300 Oct. 3 at 8:00 PM
$TEM All-Time HIGH close!!!
0 · Reply
Parnell8
Parnell8 Oct. 3 at 7:43 PM
$TEM on schedule here come the shorts to prevent the 90 close
0 · Reply
healthcareguru
healthcareguru Oct. 3 at 7:03 PM
$CLPT $GRAL $QSI $TEM $KMTS Don’t get yourself trapped holding the trash with no floor, no valuation support into the weekend…this will end horrificly for you. All have >50% downside near-term. Miss/cuts coming & bleeding cash. 🐺👎
4 · Reply
Alixc
Alixc Oct. 3 at 6:49 PM
$TEM heart attack
0 · Reply
ScreamLikeABaby
ScreamLikeABaby Oct. 3 at 6:13 PM
$TEM The indexes suddenly tanked without explanation. But we're still green 💚
0 · Reply
BasicTrader
BasicTrader Oct. 3 at 5:30 PM
$TEM that abandoned two hour candle doesn’t happen that often. Are we dumping it now and shorting?
0 · Reply
Watchmeplz
Watchmeplz Oct. 3 at 5:04 PM
$AFRM buy buy buy! Opportunity knocks! $MSFT $TEM $PYPL $GOOG
0 · Reply
dukeofhb
dukeofhb Oct. 3 at 4:58 PM
$TEM not a super convincing breakout yet, but it’s holding above 90 for the longest period yet so far. Curious to see what happens on weekly opex. But I’m liking the chances of 100 more and more. Keeps making higher lows each attempt into the 90s
0 · Reply